Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Point-of-Care Testing | 1 | 2025 | 29 | 0.890 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2025 | 29 | 0.880 |
Why?
|
| Parkinson Disease | 1 | 2025 | 186 | 0.760 |
Why?
|
| Papilledema | 1 | 2021 | 4 | 0.670 |
Why?
|
| Diabetes Complications | 1 | 2021 | 176 | 0.600 |
Why?
|
| Optic Neuropathy, Ischemic | 2 | 2016 | 23 | 0.590 |
Why?
|
| Vision Disorders | 2 | 2009 | 72 | 0.530 |
Why?
|
| Giant Cell Arteritis | 1 | 2016 | 6 | 0.500 |
Why?
|
| Eyelid Neoplasms | 1 | 2014 | 7 | 0.420 |
Why?
|
| Sarcoma, Myeloid | 1 | 2014 | 14 | 0.420 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 16 | 0.420 |
Why?
|
| Neurodegenerative Diseases | 1 | 2009 | 59 | 0.290 |
Why?
|
| Visual Acuity | 2 | 2021 | 192 | 0.280 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 850 | 0.260 |
Why?
|
| Protein Folding | 1 | 2009 | 291 | 0.260 |
Why?
|
| Sella Turcica | 1 | 2006 | 18 | 0.240 |
Why?
|
| Ophthalmology | 1 | 2006 | 42 | 0.230 |
Why?
|
| Neurology | 1 | 2006 | 84 | 0.220 |
Why?
|
| Eye Diseases | 1 | 2024 | 58 | 0.200 |
Why?
|
| Autoimmune Diseases | 1 | 2024 | 261 | 0.170 |
Why?
|
| Pupil Disorders | 1 | 2021 | 3 | 0.170 |
Why?
|
| Visual Field Tests | 1 | 2021 | 16 | 0.170 |
Why?
|
| Photography | 1 | 2021 | 43 | 0.160 |
Why?
|
| Tomography, Optical Coherence | 1 | 2021 | 130 | 0.160 |
Why?
|
| Reproducibility of Results | 1 | 2025 | 2792 | 0.140 |
Why?
|
| Charles Bonnet Syndrome | 1 | 2018 | 1 | 0.140 |
Why?
|
| Cataract Extraction | 1 | 2018 | 31 | 0.130 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2017 | 2 | 0.130 |
Why?
|
| Vision, Low | 1 | 2017 | 15 | 0.130 |
Why?
|
| Cataract | 1 | 2018 | 87 | 0.130 |
Why?
|
| Humans | 10 | 2025 | 98370 | 0.120 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2014 | 1 | 0.110 |
Why?
|
| Optic Nerve Injuries | 1 | 2014 | 4 | 0.110 |
Why?
|
| Optic Neuritis | 1 | 2014 | 9 | 0.110 |
Why?
|
| Blindness | 1 | 2014 | 39 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2014 | 295 | 0.100 |
Why?
|
| Aged | 2 | 2025 | 21844 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2025 | 3612 | 0.100 |
Why?
|
| Prognosis | 1 | 2021 | 4126 | 0.090 |
Why?
|
| Male | 4 | 2025 | 47263 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1752 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1570 | 0.080 |
Why?
|
| Incidence | 1 | 2014 | 1787 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2017 | 0.070 |
Why?
|
| Female | 3 | 2025 | 51761 | 0.070 |
Why?
|
| Brain | 1 | 2018 | 2439 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2009 | 931 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 4044 | 0.060 |
Why?
|
| Skull Neoplasms | 1 | 2006 | 25 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2014 | 2599 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 2006 | 74 | 0.060 |
Why?
|
| Risk Factors | 1 | 2016 | 6273 | 0.060 |
Why?
|
| Middle Aged | 1 | 2025 | 29532 | 0.050 |
Why?
|
| Young Adult | 1 | 2014 | 7568 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 2018 | 45 | 0.030 |
Why?
|
| Ubiquinone | 1 | 2017 | 10 | 0.030 |
Why?
|
| Antioxidants | 1 | 2017 | 236 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 2678 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 7418 | 0.020 |
Why?
|
| Animals | 1 | 2006 | 28981 | 0.020 |
Why?
|
| Child | 1 | 2017 | 7750 | 0.010 |
Why?
|